{No title}
- Funded by Ministry for Innovation and Technology (Hungary)
- Total publications:0 publications
Grant search
Key facts
Disease
COVID-19Funder
Ministry for Innovation and Technology (Hungary)Principal Investigator
Unspecified Unspecified UnspecifiedResearch Location
HungaryLead Research Institution
Eötvös Lóránd Research NetworkResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
With the involvement of the Eötvös Lóránd Research Network, the development of a highly effective inhibitor has begun to treat and possible prevent the coronavirus infection. The hyperacute serum therapy that is also under development plans to use the antibodies that are produced in the blood of people who have overcome a coronavirus infection to treat patients. Other research projects are in preparation with relation to the development of agents that could slow and curb the spread of the infection, medical equipment to support hospital care, and expanding Hungary's production capacities.